New Wilms tumor treated with proton beam abdominal radiation
Part of Cancer, Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies a specific type of radiation (proton beam) given to the abdomen after surgery and/or chemotherapy in children and young people with newly diagnosed Wilms tumor. The goal is to improve cancer control while carefully targeting radiation to the right stage of disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being diagnosed with Wilms tumor now, or are starting abdominal radiation after surgery.
- Your tumor type must be favorable histology Wilms tumor (if the tumor looks “unfavorable,” you may not receive the study treatment).
- Your treatment timing must fit: if you had upfront surgery, radiation should start soon (within about 4 weeks).
- You should be able to do daily activities at least at a moderate level (performance score ≥50 depending on age).
- You must not have had prior abdominal radiation for the current treatment field.
- If you can become pregnant (age ~10+ or after first period), you must have a negative pregnancy test before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests a type of radiation delivery (“pencil beam scanning”) for certain kidney cancers in children and teens. It may help doctors better target the tumor while reducing radiation to nearby healthy tissue.
This Phase 1/2 trial studies metronomic (very low, steady) chemotherapy taken by mouth or through a feeding tube for children with Wilms tumor that has come back or not responded to earlier treatment. It aims to shrink measurable tumors with better long-term tolerability than standard chemotherapy.
This study tests a new way to plan proton radiation therapy (a precise type of cancer treatment) for children with solid tumors or Hodgkin's lymphoma. The goal is to improve how doctors adapt treatment during therapy to better target tumors while protecting healthy tissue.
This study tailors treatment for children with Wilms tumor based on specific tumor features and risk factors. The goal is to give the right amount of therapy to each patient to minimize side effects while maintaining high cure rates.
This Phase 2 trial tests combination chemotherapy for children with certain types of Wilms tumor—either newly diagnosed diffuse anaplastic Wilms tumor or favorable Wilms tumor that has come back. The goal is to see how well the treatment controls the tumor and is tolerable for children.
This trial uses a precise type of proton beam radiation to treat children with neuroblastoma in the belly area. The goal is to see how well this targeted radiation works and to monitor its side effects.
Hear when a new Wilms Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.